Aligos' fatty liver disease treatment meets main goal in mid-stage study
(Reuters) - Aligos Therapeutics said on Thursday its experimental treatment for a serious type of fatty liver disease helped significantly reduce liver fat, meeting the main goal of a mid-stage study.
(Reporting by Mariam Sunny in Bengaluru; Editing by Vijay Kishore)